Tennessee's attempt to execute convicted murderer Christa Pike by lethal injection has ended in startling failure, leaving the 50-year-old inmate hospitalized and authorities scrambling to explain how a procedure designed to end her life did not do so. The case, already the focus of a fierce legal battle that reached the US Supreme Court, has now triggered a fresh wave of questions about execution protocols, the reliability of lethal injection drugs, and the suffering of prisoners when an execution does not unfold as planned.
Pike was sentenced to death in 1996 for the murder of 19-year-old Colleen Slemmer, an attack she carried out alongside her then-boyfriend, Tadaryl Shipp. Her execution had been scheduled for Wednesday evening local time. The injections were ultimately permitted by the US Supreme Court at the eleventh hour, following a protracted legal fight over whether the state could proceed.
According to her legal team, Pike was administered two syringes of the drug pentobarbital, yet the doses failed to stop her heartbeat. Lawyers said she could still be heard snoring after the second injection. The Tennessee Department of Correction has publicly defended its method, stating that "the protocol does not allow for additional procedures beyond what was carried out this evening."
That defense has not resolved the central mystery of why the dosage proved non-fatal. The state's written protocol does not clearly set out what should be done if an inmate remains alive after a second dose of the drug, according to the AP news agency. Authorities have not yet offered their own explanation, though medical specialists have proposed theories.
Dr Joel Zivot, a professor at Emory University School of Medicine who told the BBC he had been retained by Pike's legal team as a medical expert, suggested she likely never reached a blood concentration of pentobarbital sufficient to trigger apnoea and cardiovascular failure. In emailed remarks, Zivot also warned that the delay in beginning resuscitation could leave Pike with a brain injury. Her legal team has separately alleged that the pentobarbital used was "degraded" — a claim the correction department has not directly addressed, instead issuing a broad defense that "the lethal injection chemical in the protocol has consistently been effective."
Following the failed procedure, Pike was transferred to an off-site medical facility. One of her lawyers said she was "being provided life-saving measures" in hospital, and her condition remained unclear as of Thursday morning. The state's governor, Bill Lee, has ordered a third-party review of what happened and announced that the year's last remaining execution in Tennessee will not go ahead as planned. It is not yet known whether authorities will attempt to execute Pike a second time, though there is historical precedent in the US for states making repeated attempts on death row inmates.
The human dimensions of the case have drawn sharp reactions from both sides. May Martinez, the mother of victim Colleen Slemmer and a longtime advocate for Pike's execution, described the events to NBC News as "a mess." Meanwhile, opponents of capital punishment seized on the failure as evidence of a deeply flawed system. Maya Foa, chief executive of the international legal organization Reprieve, said the public cannot know exactly what went wrong because so much occurs behind a curtain, arguing that lethal injection "relies on secrecy at every stage, to hide the violence of the state taking a human life."
Pike's co-defendant, Shipp, remains imprisoned but was spared the death penalty because he was 17 at the time of the killing, making him a juvenile under state law. Slemmer, the victim, was tortured and brutally killed during the 1995 attack in Knoxville.
At the center of the controversy is pentobarbital itself. It is a powerful sedative that depresses the body's systems, including the nervous system. While doctors sometimes prescribe it to treat certain medical conditions, in high doses it can be used to cause death in an execution. Its role in lethal injections came under renewed scrutiny last year following a US federal government review conducted during Joe Biden's presidency, which raised concerns about the drug's potential to cause "unnecessary pain and suffering." Biden's administration banned its use in federal executions, but that decision did not bind individual states such as Tennessee, which retain the authority to select their own execution methods.
In recent years, states have struggled to obtain some of the drugs required for lethal injections, as pharmaceutical companies have increasingly opposed the use of their products for capital punishment. This scarcity has fueled debate over the sourcing, storage, and quality of execution drugs — issues now central to the questions surrounding Pike's case. Drugs can degrade for various reasons, including being kept beyond their use-by date, which can reduce their potency.
Wednesday's events are not the first time Tennessee's execution process has gone awry in 2026. In May, the scheduled execution of Tony Carruthers — convicted of kidnapping and murdering three people in 1994 — was postponed after staff could not locate a vein to administer the lethal injection. Governor Lee granted him a one-year reprieve.
The problem extends well beyond Tennessee. Nationwide, botched or highly problematic executions continue to alarm observers. According to the Death Penalty Information Center, a research organization that does not take a formal stance on capital punishment, more than a third of US executions in 2022 were botched or otherwise seriously flawed. Pike's case now stands as the latest and most dramatic illustration of those concerns, raising urgent questions about what the state will do next — and what it owes an inmate who was meant to die but did not.
(0)